Intravenous Fosfomycin: A Potential Good Partner for Cefiderocol. Clinical Experience and Considerations

Intravenous Fosfomycin: A Potential Good Partner for Cefiderocol. Clinical Experience and Considerations

Multidrug resistant Gram-negative bacteremia represents a therapeutic challenge clinicians have to deal with. This concern becomes more difficult when causing germs are represented by carbapenem resistant <i>Acinetobacter baumannii</i> or difficult-to-treat <i>Pseudomonas aeruginos...

Full description

Bibliographic Details
Main Authors: Andrea Marino, Stefano Stracquadanio, Edoardo Campanella, Antonio Munafò, Maria Gussio, Manuela Ceccarelli, Renato Bernardini, Giuseppe Nunnari, Bruno Cacopardo
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Antibiotics
Subjects:
cefiderocol
novel antimicrobial strategies
intravenous fosfomycin
<i>Pseudomonas aeruginosa</i>
<i>Acinetobacter baumannii</i>
MDR Gram negative bacteria
Online Access:https://www.mdpi.com/2079-6382/12/1/49

Internet

https://www.mdpi.com/2079-6382/12/1/49

Similar Items